{
    "clinical_study": {
        "@rank": "156604", 
        "brief_summary": {
            "textblock": "To compare the toxicity profiles (severity and time to onset from initiation of therapy)\n      between daunorubicin (liposomal) and combination chemotherapy with\n      doxorubicin/bleomycin/vincristine (ABV), with both regimens administered in combination with\n      antiretroviral therapy. To compare the duration of responses, response rates, and times to\n      response."
        }, 
        "brief_title": "A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.", 
        "condition": [
            "Sarcoma, Kaposi", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Sarcoma, Kaposi", 
                "Sarcoma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  HIV infection.\n\n          -  Advanced Kaposi's sarcoma.\n\n        Prior Medication:\n\n        Allowed:\n\n          -  Prior intralesional vinblastine.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms and conditions are excluded:\n\n          -  Acute intercurrent infection other than genital herpes.\n\n          -  Uncompensated cardiovascular, hepatic, renal, or pulmonary disease unrelated to\n             Kaposi's sarcoma.\n\n          -  Symptomatic peripheral neuropathy.\n\n          -  Any condition that compromises ability to give informed consent or complete the\n             study.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Concurrent ganciclovir.\n\n        Patients with the following prior conditions are excluded:\n\n          -  Symptomatic AIDS-defining opportunistic infection within 2 weeks of entry.\n\n          -  History of malignancy other than Kaposi's sarcoma, basal cell carcinoma, or carcinoma\n             in situ of the cervix.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Prior systemic chemotherapy.\n\n          -  Intralesional therapies within 7 days prior to study entry.\n\n          -  Growth factors (G-CSF or GM-CSF), immune modifiers, or investigational agents within\n             14 days prior to study entry.\n\n          -  Interferon preparations (alpha or beta) within 28 days prior to study entry.\n\n        Prior Treatment:\n\n        Excluded within 7 days prior to study entry:\n\n          -  Radiation.\n\n          -  Local therapies (e.g., cryotherapy)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002093", 
            "org_study_id": "121A", 
            "secondary_id": "103-09"
        }, 
        "intervention": [
            {
                "intervention_name": "Daunorubicin (liposomal)", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Bleomycin sulfate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Vincristine sulfate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Doxorubicin hydrochloride", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Bleomycin", 
                "Daunorubicin", 
                "Doxorubicin", 
                "Vincristine"
            ]
        }, 
        "keyword": [
            "Vincristine", 
            "Sarcoma, Kaposi", 
            "Liposomes", 
            "Doxorubicin", 
            "Acquired Immunodeficiency Syndrome", 
            "Bleomycin", 
            "Daunorubicin", 
            "Drug Carriers"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85724"
                    }, 
                    "name": "Univ of Arizona / Arizona Cancer Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "Kenneth Norris Jr Cancer Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palm Springs", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92262"
                    }, 
                    "name": "Desert Hosp Comprehensive Cancer Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94114"
                    }, 
                    "name": "Davies Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94109"
                    }, 
                    "name": "Saint Francis Mem Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "802044507"
                    }, 
                    "name": "Denver Gen Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20037"
                    }, 
                    "name": "George Washington Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33136"
                    }, 
                    "name": "Univ of Miami Dept of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "Northwestern Univ Med School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "New England Deaconess Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "New York Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97227"
                    }, 
                    "name": "Kaiser Permanente Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77004"
                    }, 
                    "name": "Dr Edward Stool"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "reference": [
            {
                "PMID": "8708728", 
                "citation": "Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol. 1996 Aug;14(8):2353-64."
            }, 
            {
                "citation": "Savage GE, Gable C, Motte K, Dixon C, Becker R. A pharmacoeconomic analysis of Kaposi's sarcoma patients based on a clinical trial of ABV vs. DaunoXome. Int Conf AIDS. 1996 Jul 7-12;11(Program Supplement):32 (abstract no LBB6048)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002093"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nexstar Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Allocation: Randomized, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 1996"
    }, 
    "geocoordinates": {
        "Davies Med Ctr": "37.775 -122.419", 
        "Denver Gen Hosp": "39.739 -104.985", 
        "Desert Hosp Comprehensive Cancer Ctr": "33.83 -116.545", 
        "Dr Edward Stool": "29.76 -95.369", 
        "George Washington Univ Med Ctr": "38.895 -77.036", 
        "Kaiser Permanente Med Ctr": "45.523 -122.676", 
        "Kenneth Norris Jr Cancer Hosp": "34.052 -118.244", 
        "New England Deaconess Hosp": "42.358 -71.06", 
        "New York Univ Med Ctr": "40.714 -74.006", 
        "Northwestern Univ Med School": "41.878 -87.63", 
        "Saint Francis Mem Hosp": "37.775 -122.419", 
        "Univ of Arizona / Arizona Cancer Ctr": "32.222 -110.926", 
        "Univ of Miami Dept of Medicine": "25.789 -80.226"
    }
}